Skip to main content
Top
Published in: International Urology and Nephrology 10/2023

27-06-2023 | Kidney Transplantation | Urology - Original Paper

Comparison of the Charlson comorbidity index, the modified Charlson comorbidity index, and the recipient risk score in prediction of the graft and patient survival among renal graft recipients: historical cohort in a single center

Authors: Navid Masoumi, Majed Ghaffari, Majid Ali Asgari, Mehdi Dadpour

Published in: International Urology and Nephrology | Issue 10/2023

Login to get access

Abstract

Objective

To compare the predictive values of Charlson comorbidity index (CCI), modified Charlson comorbidity index kidney transplant (mCCI-KT) and recipient risk score (RRS) indices in prediction of patient and graft survival in kidney transplant patients.

Methods

In this retrospective study, all patients who underwent a live-donor KT from 2006 to 2010, were included. Demographic data, comorbidities and survival time after KT were extracted and the association between above indices with patient and graft survival were compared.

Results

In ROC curve analysis of 715 included patients, all three indicators were weak in predicting graft rejection with the area under curve (AUC) less than 0.6. The best models for predicting the overall survival were mCCI-KT and CCI with AUC of 0.827 and 0.780, respectively. Sensitivity and specificity of mCCI-KT at cut point of 1 were 87.2 and 75.6. Sensitivity and specificity of CCI at cut point of 3 were 84.6 and 68.3 and for RRS at cut point of 3 were 51.3 and 81.2, respectively.

Conclusion

The mCCI-KT index followed by the CCI index provided the best model in predicting the 10-year patient survival; however, they were poor in predicting graft survival and this model can be used for better stratifying transplant candidates prior to surgery.
Appendix
Available only for authorised users
Literature
1.
go back to reference Schold JD et al (2014) Association between kidney transplant center performance and the survival benefit of transplantation versus dialysis. Clin J Am Soc Nephrol 9(10):1773–1780CrossRefPubMedPubMedCentral Schold JD et al (2014) Association between kidney transplant center performance and the survival benefit of transplantation versus dialysis. Clin J Am Soc Nephrol 9(10):1773–1780CrossRefPubMedPubMedCentral
2.
go back to reference Pieloch D et al (2015) The Kidney Transplant Morbidity Index (KTMI): a simple prognostic tool to help determine outcome risk in kidney transplant candidates. Prog Transplant 25(1):70–76CrossRefPubMed Pieloch D et al (2015) The Kidney Transplant Morbidity Index (KTMI): a simple prognostic tool to help determine outcome risk in kidney transplant candidates. Prog Transplant 25(1):70–76CrossRefPubMed
3.
go back to reference Fried L, Bernardini J, Piraino B (2001) Charlson comorbidity index as a predictor of outcomes in incident peritoneal dialysis patients. Am J Kidney Dis 37(2):337–342CrossRefPubMed Fried L, Bernardini J, Piraino B (2001) Charlson comorbidity index as a predictor of outcomes in incident peritoneal dialysis patients. Am J Kidney Dis 37(2):337–342CrossRefPubMed
4.
go back to reference van Manen JG et al (2002) How to adjust for comorbidity in survival studies in ESRD patients: a comparison of different indices. Am J Kidney Dis 40(1):82–89CrossRefPubMed van Manen JG et al (2002) How to adjust for comorbidity in survival studies in ESRD patients: a comparison of different indices. Am J Kidney Dis 40(1):82–89CrossRefPubMed
5.
go back to reference Hemmelgarn BR et al (2003) Adapting the Charlson Comorbidity Index for use in patients with ESRD. Am J Kidney Dis 42(1):125–132CrossRefPubMed Hemmelgarn BR et al (2003) Adapting the Charlson Comorbidity Index for use in patients with ESRD. Am J Kidney Dis 42(1):125–132CrossRefPubMed
6.
7.
go back to reference Khan IH et al (1993) Influence of coexisting disease on survival on renal-replacement therapy. Lancet 341(8842):415–418CrossRefPubMed Khan IH et al (1993) Influence of coexisting disease on survival on renal-replacement therapy. Lancet 341(8842):415–418CrossRefPubMed
8.
go back to reference Davies SJ et al (1995) Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: their interrelationship and prediction of survival. Am J Kidney Dis 26(2):353–361CrossRefPubMed Davies SJ et al (1995) Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: their interrelationship and prediction of survival. Am J Kidney Dis 26(2):353–361CrossRefPubMed
9.
go back to reference Foley RN et al (1994) Advance prediction of early death in patients starting maintenance dialysis. Am J Kidney Dis 23(6):836–845CrossRefPubMed Foley RN et al (1994) Advance prediction of early death in patients starting maintenance dialysis. Am J Kidney Dis 23(6):836–845CrossRefPubMed
10.
go back to reference Baskin-Bey ES, Kremers W, Nyberg SL (2007) A recipient risk score for deceased donor renal allocation. Am J Kidney Dis 49(2):284–293CrossRefPubMed Baskin-Bey ES, Kremers W, Nyberg SL (2007) A recipient risk score for deceased donor renal allocation. Am J Kidney Dis 49(2):284–293CrossRefPubMed
11.
go back to reference Baskin-Bey ES, Nyberg SL (2008) Matching graft to recipient by predicted survival: can this be an acceptable strategy to improve utilization of deceased donor kidneys? Transplant Rev (Orlando) 22(3):167–170CrossRefPubMed Baskin-Bey ES, Nyberg SL (2008) Matching graft to recipient by predicted survival: can this be an acceptable strategy to improve utilization of deceased donor kidneys? Transplant Rev (Orlando) 22(3):167–170CrossRefPubMed
12.
go back to reference Moore J et al (2011) Mortality prediction after kidney transplantation: comparative clinical use of 7 comorbidity indices. Exp Clin Transplant 9(1):32–41PubMed Moore J et al (2011) Mortality prediction after kidney transplantation: comparative clinical use of 7 comorbidity indices. Exp Clin Transplant 9(1):32–41PubMed
13.
go back to reference Park JY et al (2018) Comorbidities can predict mortality of kidney transplant recipients: comparison with the Charlson Comorbidity Index. Transplantation proceedings. Elsevier, Amsterdam Park JY et al (2018) Comorbidities can predict mortality of kidney transplant recipients: comparison with the Charlson Comorbidity Index. Transplantation proceedings. Elsevier, Amsterdam
14.
go back to reference Hallan SI et al (2006) International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 17(8):2275–2284CrossRefPubMed Hallan SI et al (2006) International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 17(8):2275–2284CrossRefPubMed
15.
go back to reference Grassmann A et al (2005) ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant 20(12):2587–2593CrossRefPubMed Grassmann A et al (2005) ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant 20(12):2587–2593CrossRefPubMed
16.
go back to reference Charlson ME et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRefPubMed Charlson ME et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRefPubMed
17.
go back to reference Pirsch JD et al (1996) Determinants of graft survival after renal transplantation. Transplantation 61(11):1581–1586CrossRefPubMed Pirsch JD et al (1996) Determinants of graft survival after renal transplantation. Transplantation 61(11):1581–1586CrossRefPubMed
18.
go back to reference O’Shaughnessy EA et al (2002) Risk factors for fractures in kidney transplantation. Transplantation 74(3):362–366CrossRefPubMed O’Shaughnessy EA et al (2002) Risk factors for fractures in kidney transplantation. Transplantation 74(3):362–366CrossRefPubMed
19.
go back to reference Grosso G et al (2012) Predictive value of the Charlson comorbidity index in kidney transplantation. Transplantation proceedings. Elsevier, Amsterdam Grosso G et al (2012) Predictive value of the Charlson comorbidity index in kidney transplantation. Transplantation proceedings. Elsevier, Amsterdam
20.
go back to reference Jassal SV, Schaubel DE, Fenton SS (2005) Baseline comorbidity in kidney transplant recipients: a comparison of comorbidity indices. Am J Kidney Dis 46(1):136–142CrossRefPubMed Jassal SV, Schaubel DE, Fenton SS (2005) Baseline comorbidity in kidney transplant recipients: a comparison of comorbidity indices. Am J Kidney Dis 46(1):136–142CrossRefPubMed
21.
go back to reference Hirsch HH (2002) Polyomavirus BK nephropathy: a (re-)emerging complication in renal transplantation. Am J Transplant 2(1):25–30CrossRefPubMed Hirsch HH (2002) Polyomavirus BK nephropathy: a (re-)emerging complication in renal transplantation. Am J Transplant 2(1):25–30CrossRefPubMed
22.
go back to reference Hirsch HH et al (2005) Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 79(10):1277–1286CrossRefPubMed Hirsch HH et al (2005) Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 79(10):1277–1286CrossRefPubMed
23.
go back to reference Fried L, Bernardini J, Piraino B (2003) Comparison of the Charlson comorbidity index and the Davies score as a predictor of outcomes in PD patients. Perit Dial Int 23(6):568–573CrossRefPubMed Fried L, Bernardini J, Piraino B (2003) Comparison of the Charlson comorbidity index and the Davies score as a predictor of outcomes in PD patients. Perit Dial Int 23(6):568–573CrossRefPubMed
24.
go back to reference Rius C et al (2004) An adaptation of Charlson comorbidity index predicted subsequent mortality in a health survey. J Clin Epidemiol 57(4):403–408CrossRefPubMed Rius C et al (2004) An adaptation of Charlson comorbidity index predicted subsequent mortality in a health survey. J Clin Epidemiol 57(4):403–408CrossRefPubMed
25.
go back to reference McArthur E et al (2018) Comparing five comorbidity indices to predict mortality in chronic kidney disease: a retrospective cohort study. Can J Kidney Health Dis 5:2054358118805418CrossRefPubMedPubMedCentral McArthur E et al (2018) Comparing five comorbidity indices to predict mortality in chronic kidney disease: a retrospective cohort study. Can J Kidney Health Dis 5:2054358118805418CrossRefPubMedPubMedCentral
26.
go back to reference Krikov S et al (2007) Predicting kidney transplant survival using tree-based modeling. Asaio J 53(5):592–600CrossRefPubMed Krikov S et al (2007) Predicting kidney transplant survival using tree-based modeling. Asaio J 53(5):592–600CrossRefPubMed
27.
go back to reference Djaladat H et al (2014) The association of preoperative serum albumin level and American Society of Anesthesiologists (ASA) score on early complications and survival of patients undergoing radical cystectomy for urothelial bladder cancer. BJU Int 113(6):887–893CrossRefPubMed Djaladat H et al (2014) The association of preoperative serum albumin level and American Society of Anesthesiologists (ASA) score on early complications and survival of patients undergoing radical cystectomy for urothelial bladder cancer. BJU Int 113(6):887–893CrossRefPubMed
Metadata
Title
Comparison of the Charlson comorbidity index, the modified Charlson comorbidity index, and the recipient risk score in prediction of the graft and patient survival among renal graft recipients: historical cohort in a single center
Authors
Navid Masoumi
Majed Ghaffari
Majid Ali Asgari
Mehdi Dadpour
Publication date
27-06-2023
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 10/2023
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-023-03670-6

Other articles of this Issue 10/2023

International Urology and Nephrology 10/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine